Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
Go back to Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease| Pfizer Inc. (NYSE: PFE) | Delayed: 26.32 +0.06 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.26 | 52 Week High | $37.39 | |||
| Open | $26.33 | 52 Week Low | $28.25 | |||
| Day High | $26.47 | P/E | 15.95 | |||
| Day Low | $26.19 | EPS | $1.65 | |||
| Volume | 24,295,728 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.32 +0.06 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.26 | 52 Week High | $37.39 | |||
| Open | $26.33 | 52 Week Low | $28.25 | |||
| Day High | $26.47 | P/E | 15.95 | |||
| Day Low | $26.19 | EPS | $1.65 | |||
| Volume | 24,295,728 | |||||
